Cita APA

Márquez-Rodas, I., Vidal, J., Foro Arnalot, P., & Berrocal Jaime, A. (2024). Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study).

Citación estilo Chicago

Márquez-Rodas, Iván, Joana Vidal, Palmira Foro Arnalot, y Alfonso Berrocal Jaime. Encorafenib and Binimetinib Followed By Radiotherapy for Patients With BRAFV600-mutant Melanoma and Brain Metastases (E-BRAIN/GEM1802 Phase II Study). 2024.

Cita MLA

Márquez-Rodas, Iván, Joana Vidal, Palmira Foro Arnalot, y Alfonso Berrocal Jaime. Encorafenib and Binimetinib Followed By Radiotherapy for Patients With BRAFV600-mutant Melanoma and Brain Metastases (E-BRAIN/GEM1802 Phase II Study). 2024.